Results 21 to 30 of about 990,536 (371)
Natriuretic peptides and cardiovascular damage in the metabolic syndrome. Molecular mechanisms and clinical implications [PDF]
, 2010 Natriuretic peptides are endogenous antagonists of vasoconstrictor and salt- and water-retaining systems in the body's defence against blood pressure elevation and plasma volume expansion, through direct vasodilator, diuretic and natriuretic properties ...
ALONZO, ALESSANDRO +4 more
core +1 more source
Modified natriuretic peptides and their potential roles in cancer treatment
Biomedical Journal, 2022 The natriuretic peptide family (NPs) is a group of natural endocrine hormones, containing a 17-amino acid ring structure connected by disulfide bonds of two cysteines.
Mengjiao Xu +9 more
doaj +1 more source
Natriuretic peptides appeared after their receptors in vertebrates
BMC Evolutionary Biology, 2019 Background In mammals, the natriuretic system contains three natriuretic peptides, NPPA, NPPB and NPPC, that bind to three transmembrane receptors, NPR1, NPR2 and NPR3. The natriuretic peptides are known only in vertebrates.
Anna Grandchamp +2 more
doaj +1 more source
Comprehensive exploration of unexplained dyspnoea in subjects with normal ejection fraction and low natriuretic peptides. [PDF]
ESC Heart FailAbstract Background Unexplained exertional dyspnoea without significant elevation of natriuretic peptides is common. One of the causes might be early heart failure with preserved ejection fraction (HFpEF). Aims This study aimed to characterize patients with exertional dyspnoea and normal/near‐to‐normal N‐terminal pro‐brain natriuretic peptide (NT ...
Berthelot E +8 more
europepmc +2 more sources
Natriuretic Peptides: Biochemistry, Physiology, Clinical Implication
Общая реаниматология, 2009 In the past years, the interest of theorists and clinicians has steadily increased in the myocardially secreted hormones – natriuretic peptides. At the Congress of the European Society of Anesthesiology (Munich, 2007), B-type natriuretic peptides ...
I. A. Kozlova, I. Ye. Kharlamova
doaj +1 more source
Рациональная фармакотерапия в кардиологии, 2017 A clinical role of biomarkers (especially, natriuretic peptides) is discussed in the article. The most important evidences of clinical effectiveness of using biomarkers in patients with suspected heart failure and in patients with confirmed diagnose of ...
S. R. Gilyarevskiy +2 more
doaj +1 more source
A Multi-marker Model for Predicting Decompensated Heart Failure in Patients with Prior Acute Myocardial Infarction [PDF]
, 2020 The aim of the study was to assess the prognostic value of determining the plasma concentration of NT-proBNP and ST2 in the patients with decompensated HF and prior acute myocardial infarction and their combination in this category of patients.Materials ...
Levandovska, K. (Khrystyna)
core +3 more sources
Neprilysin Inhibitors in Heart Failure
JACC: Basic to Translational Science, 2023 Summary: This article provides a contemporary review and a new perspective on the role of neprilysin inhibition in heart failure (HF) in the context of recent clinical trials and addresses potential mechanisms and unanswered questions in certain HF ...
Biykem Bozkurt, MD, PhD +5 more
doaj +1 more source
European Journal of Heart Failure, 2019 Cardiac biomarkers are a mainstay in diagnosis of cardiovascular disease but their role in cardio‐oncology has not yet been systematically evaluated. This meta‐analysis aims to determine whether cardiac troponins and (N‐terminal pro) brain natriuretic ...
L. Michel +6 more
semanticscholar +1 more source
The Multi-Biomarker Approach for Heart Failure in Patients with Hypertension [PDF]
, 2015 We assessed the predictive ability of selected biomarkers using N-terminal pro-brain natriuretic peptide (NT-proBNP) as the benchmark and tried to establish a multi-biomarker approach to heart failure (HF) in hypertensive patients. In 120 hypertensive
Agata Bielecka-Dabrowa +10 more
core +5 more sources